We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is BellRing Brands (BRBR) Outperforming Other Medical Stocks This Year?
Read MoreHide Full Article
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. BellRing Brands (BRBR - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
BellRing Brands is one of 1047 companies in the Medical group. The Medical group currently sits at #6 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. BellRing Brands is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past 90 days, the Zacks Consensus Estimate for BRBR's full-year earnings has moved 6.9% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
According to our latest data, BRBR has moved about 6.6% on a year-to-date basis. At the same time, Medical stocks have gained an average of 4.5%. This means that BellRing Brands is performing better than its sector in terms of year-to-date returns.
Another Medical stock, which has outperformed the sector so far this year, is DaVita HealthCare (DVA - Free Report) . The stock has returned 26.2% year-to-date.
In DaVita HealthCare's case, the consensus EPS estimate for the current year increased 4.2% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, BellRing Brands belongs to the Medical - Products industry, a group that includes 91 individual stocks and currently sits at #95 in the Zacks Industry Rank. This group has gained an average of 2.7% so far this year, so BRBR is performing better in this area.
In contrast, DaVita HealthCare falls under the Medical - Outpatient and Home Healthcare industry. Currently, this industry has 19 stocks and is ranked #53. Since the beginning of the year, the industry has moved +7.2%.
Investors with an interest in Medical stocks should continue to track BellRing Brands and DaVita HealthCare. These stocks will be looking to continue their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is BellRing Brands (BRBR) Outperforming Other Medical Stocks This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. BellRing Brands (BRBR - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.
BellRing Brands is one of 1047 companies in the Medical group. The Medical group currently sits at #6 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. BellRing Brands is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past 90 days, the Zacks Consensus Estimate for BRBR's full-year earnings has moved 6.9% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.
According to our latest data, BRBR has moved about 6.6% on a year-to-date basis. At the same time, Medical stocks have gained an average of 4.5%. This means that BellRing Brands is performing better than its sector in terms of year-to-date returns.
Another Medical stock, which has outperformed the sector so far this year, is DaVita HealthCare (DVA - Free Report) . The stock has returned 26.2% year-to-date.
In DaVita HealthCare's case, the consensus EPS estimate for the current year increased 4.2% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, BellRing Brands belongs to the Medical - Products industry, a group that includes 91 individual stocks and currently sits at #95 in the Zacks Industry Rank. This group has gained an average of 2.7% so far this year, so BRBR is performing better in this area.
In contrast, DaVita HealthCare falls under the Medical - Outpatient and Home Healthcare industry. Currently, this industry has 19 stocks and is ranked #53. Since the beginning of the year, the industry has moved +7.2%.
Investors with an interest in Medical stocks should continue to track BellRing Brands and DaVita HealthCare. These stocks will be looking to continue their solid performance.